6 launches in three years. How about 1 in three, 3 never And 2 in four years and that's a maybe. Do t forget 5.5 billion dollars in debt due in next 5 years. Save a billion a year just for debt. No problem. No new products to off set oformev in 2 years and all that R&D cost for the soon to be failed 6 launches in 3-4 years. Acthar downward pressure and if Praxair hits the market. Smooth sailing.
Exactly, not sure what they are smoking at corporate. They might have posted good earnings for q2, but increased pressure on Acthar, Innomax, and huge debt load in the near term. Everyone has seen drug delays or denials in the past. So the upcoming launches are not a given. Its a very unstable future. Critical care teams shouldn't be so arrogant You'll see.
Go home you all losers !! Business is solid. Mallinckrodt will rise again! MAGA MAKE ACTHAR GREAT AGAIN!
The expected launches are a joke...FDA laughed us out of the room...1st in history ad board voted 19 to 2 that our drug research not up to par on trelli... other drugs shoved down to submission weather regulatory wants to or not...several have jumped ship on the inside
MNK clinical team couldn’t get baby aspirin approved with a $100 million budget and 10 years to do it. Good luck believing in your pipeline. We’ll be crushed by our debt before we see any of them approved.
Ain't seen nothing yet, wait til you see the useless turds in New products commercialization. LMFAO, bunch of rejects from launch unexcellence from big pharma
Check in with the Acquire to Invest Scoreboard 1. Medicines Company acquisition- DUMPED for next to nothing, Baxter is thanking us for bringing down the price for a cheap pick up on their part 2. Stansawhatever 21 (Nay) - 3 (yea) must have been a 65 yard field goal lets wait 3-4 years for that -2022 3. Turlipressin So far its been 0 for 2, guess perseverance and third time will work doubtful it gets approved, ever 4. Succampo acquisitions LOL! trash for 1.2 Billion??? some of the VTS-270 trials conclude in 2022 5. Ocera - missed primary end point and we still buy it? "Launch" expected by 2022, bet on the denial by FDA For all the so called leaders (VPs and above) with great ideas and experience seems none of this stuff comes to market for 3-5 years. This week, we laid people off, in 6 months more to come, 12 months even more. If it wasn't you this week, its coming your way. You've been notified. Don't act surprised when your hit. I am outta here
not true . We have an innovative self auto injector coming for Acthar in 2020. This could be a game changer.
LMFAO, really? Auto injector? I am laughing so hare my belly hurts. Who will pay? No one- you need to STFU! Loser
The faster you whiners and bichers leave the better. Please leave and don't ever come back begging for your old job back.
OMG! LMAO! Are you on the opioids you sell???? No one will EVER beg to come back to this shit show. This must be some Home office Jockey guzzling the kool aid. The F---ing Loser is you!
